Occult breast cancer and axillary mass

Current Treatment Options in Oncology

Volumn 2, Issue 2, 2001, Pages 149-155

  Brill, Kristin L ^a   Brenin, David R ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Axillary Dissection; Breast Cancer; Breast Conservation; Invasive Lobular Carcinoma; Lymphedema

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CMF PROTOCOL; FLUOROURACIL; METHOTREXATE;

AXILLA; BREAST TUMOR; DECISION TREE; FEMALE; HUMAN; MASTECTOMY; METASTASIS; MORTALITY; NEOPLASM; PATHOLOGY; PRACTICE GUIDELINE; REVIEW;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AXILLA; BREAST NEOPLASMS; CISPLATIN; DECISION TREES; FEMALE; FLUOROURACIL; HUMANS; MASTECTOMY; METHOTREXATE; NEOPLASMS, UNKNOWN PRIMARY; PRACTICE GUIDELINES;

EID: 0035323401     PISSN: 15272729     EISSN: 15346277     Source Type: Journal    
DOI: 10.1007/s11864-001-0057-x     Document Type: Article

References (24)

1. Kemeny MM, Rivera De, Terz JJ, Benfield JR: Occult primary adenocarcinoma with axillary metastases. Am J Surg 1986, 152:43–47. DOI: 10.1016/0002-9610(86)90135-2
2. Fourquet A, de la Rochefordiere A, Campana F: Occult primary cancer with metastases. In Diseases of the Breast. Harris JR, Lippman ME, Morrow M, et al., eds. Philadelphia: Lippincott Raven; 1996:892–896.
3. Baron PL, Moore MP, Kinne DW, et al.: Occult breast cancer presenting with axillary metastases: Updated management. Arch Surg 1990, 125:210.
4. Halsted W: The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907, 46:1. DOI: 10.1097/00000658-190707000-00001
5. Cameron HC: Some clinical facts regarding mammary cancer. Br Med J 1909, 1:577–582. DOI: 10.1136/bmj.1.2514.577
6. Haupt HM, Rosen PP, Kinne DW: Breast carcinoma presenting with axillary lymph node metastases. Am J Surg Pathol 1985, 9:165–175. DOI: 10.1097/00000478-198503000-00001
7. Ellerbroek N, Holmes F, Singletary E, et al.: Treatment of patients with isolated axillary nodal metastases in an occult primary carcinoma consistent with breast origin. Cancer 1990, 66:1461–1467. DOI: 10.1002/1097-0142(19901001)66:7<1461::AID-CNCR2820660704>3.0.CO;2-Z
8. Merson M, Andreola S, Galmiberti V, et al.: Breast carcinoma presenting as axillary metastases without evidence of a primary tumor. Cancer 1992, 70:504–508. DOI: 10.1002/1097-0142(19920715)70:2<504::AID-CNCR2820700221>3.0.CO;2-T
9. Morris EA, Schwartz LH, Dershaw DD, et al.: MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997, 205:437–440.
10. Obdeijn IM, Brouwers-Kuyper EM, Tilanus-Linthorst MM, et al.: MR imaging-guided sonography followed by fine-needle aspiration cytology in occult carcinoma of the breast. AJR Am J Roentgenol 2000, 174:1079–1084.
11. Orel SG, Weinstein SP, Schnall MD, et al.: Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999, 212:543–549.
12. Wei-Jei L, Jan-Show C, Kai-Mo C: Occult breast carcinoma—use of color Doppler in localization. Br C Res Treat 1996, 37:299–302. DOI: 10.1007/BF01806511
13. Avril N, Dose J, Janicke F, et al.: Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-flouro-2-deoxy-D-glucose. J Natl Cancer Inst 1996, 88:1204–1209. DOI: 10.1093/jnci/88.17.1204
14. Rosen PP, Kimmel M: Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients. Hum Pathol 1990, 21:518–523. DOI: 10.1016/0046-8177(90)90008-S
15. Patel J, Takuma N, Dutau R, et al.: Axillary lymph node metastasis from an occult breast cancer. Cancer 1981, 47:2923–2927. DOI: 10.1002/1097-0142(19810615)47:12<2923::AID-CNCR2820471231>3.0.CO;2-N
16. Vilcoq JR, Calle R, Ferme F, Veith F: Conservative treatment of axillary adenopathy due to probable subclinical breast cancer. Arch Surg 1982, 117:1136–1138.
17. Goldhirsch A, Glick JH, Gelber RD, Senn H-J: Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Natl Cancer Inst 1998, 90:1601–1608. DOI: 10.1093/jnci/90.21.1601
18. Fisher B, Constantino JP, Wickerham DL, et al.:Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 2000, 92:943–944. DOI: 10.1093/jnci/92.11.943
19. Fowble B, Gray R, Gilchrist K, et al.: Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 1988, 6:1107–1117.
20. FowbleB: Postmastectomy radiation: a modest benefit prevails for high risk patients. Cancer 1997, 79:1061–1066. One of the few studies reporting an improvement in relapsefree survival. DOI: 10.1002/(SICI)1097-0142(19970315)79:6<1061::AID-CNCR1>3.0.CO;2-J
21. Schnabel FR, Estabrook A. Surgical treatment of patients at high risk of cancer, and with unusual neoplasms and clinical presentations. In Breast Cancer. Edited by Roses DF. Churchill Livingstone; 1999:579–591.
22. Early Breast Cancer Trialsts’ Collaborative Group: Polychemotherapy for early breast cancer: an overview of the randomized trials. Lancet 1998, 352:930–942. DOI: 10.1016/S0140-6736(05)61359-1
23. Miles D: Breast cancer tumour vaccines. Cancer Treat Rev 1997, 1:S77-S85. DOI: 10.1016/S0305-7372(97)90010-4
24. Whillis D, Brown PW, Rodger A: Adenocarcinoma from an unknown primary presenting in women with an axillary mass. Clin Oncol 1990, 2:189–1992. DOI: 10.1016/S0936-6555(05)80166-9